Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Breast Cancer Drug Exemestane May Increase Fracture Risk
Feb. 8, 2012
Women taking the anti-breast cancer drug exemestane should have regular bone monitoring to assess fracture risk because the treatment speeds up loss of bone density, a study suggests.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing